Menu
The WR Grace asbestos trust, or the WRG Asbestos PI Trust started accepting claims on August 15, 2014. The purpose of the trust is to “assume all liabilities and responsibility for all PI Trust Claims.” The current payment percentage is 31.7% for the schedule value for the Expedited Review process and is $31.7% for Individual Review.
Like other trusts, the WR asbestos trust classifies asbestos-related diseases into different levels corresponding to different payment amounts.
Mesothelioma is classified as a Level VIII disease with a scheduled value of $180,000. To meet this disease level, medical/exposure criteria must be met. There must be a diagnosis of mesothelioma along with what is called Grace Exposure. This means that the claimant must have a minimum exposure to any asbestos containing products or materials that were manufactured, sold, produced, supplied, specified, distributed, or selected by Grace.
Lung Cancer 1 is classified as a level VII disease level by the WR Grace asbestos trust and has a scheduled value of $42,000. To qualify for this money, the claimant must have a diagnosis of a primary lung cancer and evidence of an underlying bilateral asbestos-related nonmalignant disease. They must have six months of exposure to WR Grace asbestos products, and medical documentation that establishes that the asbestos exposure contributed to the development of lung cancer.
This is classified as a Level VI disease level with no current scheduled payment value. The criteria to meet qualifications includes a diagnosis of a primary lung cancer, “Grace Exposure”, and medical documentation that supports the fact that the lung cancer diagnosis has to do with asbestos exposure.
A Level V disease level, with a scheduled value of $20,000, “Other Cancer” claimants must have a diagnosis of esophageal, colo-rectal, laryngeal, pharyngeal, or stomach cancer, along with evidence of an underlying asbestos-related nonmalignant disease. They must also have six months of Grace Exposure, and medical documentation supporting the fact that asbestos exposure was a contributing factor to their cancer diagnosis.
Severe Asbestosis is classified as a Level IV-A disease, according to the WR Grace asbestos trust. Its scheduled value is $50,000. To meet the criteria, the claimant must have a diagnosis of asbestosis, Grace Exposure to asbestos, and supporting medical documentation correlating the asbestosis diagnosis to asbestos exposure.
This is a Level IV-B disease level with a $50,000 scheduled value. There must be a diagnosis of diffuse pleural thickening, six months Grace Exposure, and medical documentation supporting the fact that the asbestos exposure was a contributing factor to the diagnosis.
Asbestosis/Pleural Disease has a scheduled value of $7,500 and is classified as a Level III disease by the WR Grace asbestos trust. Among other things, clients must have a diagnosis of bilateral asbestos-related nonmalignant disease, six months Grace Exposure, and supporting medical documentation connecting the disease to asbestos exposure.
This is a less severe level of the previously mentioned disease and is classified as a Level II Disease Level. It has a scheduled value of $2,500. The claimant must have a diagnosis of bilateral asbestos-related nonmalignant pleural disease, and six months of Grace Exposure
This is a Level I Disease Level with a scheduled value of $300. To be eligible, claimants must have a diagnosis of a bilateral asbestos-related nonmalignant disease or an asbestos-related malignancy that is not mesothelioma along with Grace Exposure.
If you have been diagnosed with mesothelioma or another asbestos-related disease, we can help you file a claim with the WR Grace asbestos trust, or any other viable asbestos trust fund. Our team of mesothelioma Trust Claims Specialists have the knowledge and experience to file these claims and get you your rightful compensation. It is important to note that just because a claim is filed, compensation is not guaranteed.
For more information, please call us at (800) 505-6000 or fill out our contact form.
Sources: